These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 30565711
1. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J, International Collaboration for Transfusion Medicine Guidelines. Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711 [Abstract] [Full Text] [Related]
2. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women. Kjeldsen-Kragh J, Bengtsson J. Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264 [Abstract] [Full Text] [Related]
5. HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk. Winkelhorst D, de Vos TW, Kamphuis MM, Porcelijn L, Lopriore E, Oepkes D, van der Schoot CE, de Haas M. BMJ Open; 2020 Jul 20; 10(7):e034071. PubMed ID: 32690731 [Abstract] [Full Text] [Related]
6. Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect? Alm J, Duong Y, Wienzek-Lischka S, Cooper N, Santoso S, Sachs UJ, Kiefel V, Bein G. Br J Haematol; 2022 Jul 20; 198(1):14-23. PubMed ID: 35383895 [Abstract] [Full Text] [Related]
12. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. Kamphuis MM, Paridaans N, Porcelijn L, De Haas M, Van Der Schoot CE, Brand A, Bonsel GJ, Oepkes D. BJOG; 2010 Oct 20; 117(11):1335-43. PubMed ID: 20618318 [Abstract] [Full Text] [Related]
16. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program]. Uhrynowska ME, Dębska M, Guz K, Orzińska A, Wróbel A, Maślanka K, Dębski R, Brojer E. Ginekol Pol; 2015 Jan 20; 86(1):62-6. PubMed ID: 25775877 [Abstract] [Full Text] [Related]
17. Severe neonatal thrombocytopenia due to anti-HPA-4b alloantibodies: Third report described in a Caucasian mother. Petermann R, Bianchi F, Saib L, Ferré N, Francelle N, Oudin O, Chenet C, Mammasse Y, Jallu V, Chaussade A, Cornu A, Dubray L, Mailloux A. Transfusion; 2024 Jun 20; 64(6):1167-1170. PubMed ID: 38693097 [Abstract] [Full Text] [Related]
19. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study. Refsum E, Håkansson S, Mörtberg A, Wikman A, Westgren M. Transfusion; 2018 Jan 20; 58(1):223-231. PubMed ID: 29119564 [Abstract] [Full Text] [Related]
20. Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT). Bessos H, Killie MK, Matviyenko M, Husebekk A, Urbaniak SJ. Transfus Apher Sci; 2008 Dec 20; 39(3):221-7. PubMed ID: 18945639 [Abstract] [Full Text] [Related] Page: [Next] [New Search]